Edition:
United Kingdom

Trovagene Inc (TROV.OQ)

TROV.OQ on NASDAQ Stock Exchange Capital Market

0.62USD
14 Dec 2018
Change (% chg)

$-0.01 (-2.33%)
Prev Close
$0.63
Open
$0.65
Day's High
$0.65
Day's Low
$0.61
Volume
98,160
Avg. Vol
198,448
52-wk High
$5.76
52-wk Low
$0.61

Chart for

About

Trovagene, Inc. is a clinical-stage, precision medicine oncology therapeutics company. The Company’s lead drug candidate, PCM-075, is a Polo-like Kinase 1 (PLK1) selective adenosine triphosphate (ATP) competitive inhibitor. PCM-075 has shown preclinical antitumor activity as a single agent and in synergy combinations with more... (more)

Overall

Beta: 0.37
Market Cap(Mil.): $31.68
Shares Outstanding(Mil.): 37.27
Dividend: --
Yield (%): --

Financials

  TROV.OQ Industry Sector
P/E (TTM): -- 32.18 34.39
EPS (TTM): -1.20 -- --
ROI: -144.44 13.76 14.96
ROE: -204.02 16.50 16.52

Earnings vs. Estimates